Objective. To assess gender differences in body composition (BC) in a cohort of AS patients naïve to TNF-a blockers.
Introduction
In the course of AS gender differences play an important role. Female patients have a longer delay in diagnosis and different disease characteristics compared with males [1, 2] . Several studies have demonstrated that women are less responsive to TNF-a blockers and have a shorter drug survival [35] . This might be explained by differences in body composition (BC), as women have a higher total body content of fat mass compared with men [6] . This fat mass could lead to more inflammation as adipose tissue is capable of producing inflammatory cytokines, called adipokines, including TNF-a [7, 8] . So far, only limited data are available regarding gender differences of BC in patients with AS and its influence in response to TNF-a blockers, but they suggest that being female, overweight or obese is associated with a lower rate of success [911] . These findings are based on the observed relationship between drug efficacy and BMI, which does not distinguish between muscle and fat mass [12] . A more accurate measurement of the BC can be obtained using the DXA scan. This method can measure the distribution of fat and lean tissue (mostly muscle) in the whole body as well as the regional localization, including the android and gynoid fat distribution. A high android to gynoid fat ratio is associated with an increased cardiovascular risk [13, 14] . This might be relevant because it could explain part of the increased cardiovascular risk reported in AS patients [1521] . Moreover, DXA has separate reference values for men and women, stratified by age and ethnicity. The advantages of DXA compared with other methods such as CT and MRI are the very low radiation dose and the lower costs, in combination with a very strong correlation with the gold standard CT measurements [2224] .
The main objective of this study was to assess gender differences in BC measured by DXA in a cohort of AS patients naïve to TNF-a blockers. Our secondary objectives were to compare the BC variables of our patients with the values of the reference population, and to assess the relationship between BC and disease activity parameters ASDAS and BASDAI, and with the presence of dyslipidaemia and hypertension.
Methods

Patients
The Amsterdam Rheumatology and Immunology Centre initiated a prospective cohort of axial spondyloarthritis patients (the AmSpA cohort) in 1999, in which all patients who started with TNF-a blockers were included. For this study we selected from the AmSpA cohort all the consecutive patients that fulfilled the diagnosis of AS according to the 1984 New York Criteria, were 518 years old, and had a DXA analysis before the start of TNF-a blockers. Only patients that were naïve towards treatment with biologics and who were eligible for the start of TNF-a blockers because of high disease activity were included. Clinical assessments included age, disease duration, extra-articular manifestations, use of NSAIDs, DMARDs and/or prednisone, hypertension (systolic blood pressure 5140 mmHg and/or a diastolic blood pressure 590 mmHg and/or the use of antihypertensive drugs), dyslipidaemia (total cholesterol level 56.5 mmol/l and/or use of cholesterol lowering drugs), lifestyle habits (tobacco and alcohol use, physical activity, by a yes/no questionnaire), ESR and CRP levels, ASDAS CRP and ESR (<1.3 = inactive disease; range 1.32 = moderate disease activity; range 2.13.5 = high disease activity; >3.5 = very high disease activity), and BASDAI (a cut-off of 4 is used to define active disease).
Outcome measures
To calculate the BMI, body weight was measured during patients' visits, without shoes and clothes, to the nearest 0.1 kg on a digital scale (Seca Deutschland, Hamburg, Germany). Height was measured without shoes, to the nearest 1 cm. BMI was calculated as weight/height 2 (kg/m 2 ) ratio and categorized according to sex-independent WHO categories (underweight <18.5; normal range 18.524.99; overweight range 2529.99, obese 530) [25] . BC was assessed with a whole body DXA (GE Lunar iDxa, GE Corporate for Healthcare, Madison, WI, USA) and the measurements were carried out according to the protocol of the manufacturer.
The total body mass is the sum of the total fat mass (FM), total lean mass (LM) and bone mineral content. Fat mass was reported as total fat mass (sum of trunk, both arms and legs and head), and body fat % (ratio FM/total body mass). Because absolute fat mass is dependent on height, the fat mass index was calculated [FM/height 2 (kg/ m 2 )]. The fat free mass (FFM) was calculated as LM + bone mineral content. Likewise, the fat free mass index (FFMI) was calculated [FFM/height 2 (kg/m 2 )]. The quantification of fat mass in the android and gynoid regions was carried out as previously described [26] . The caudal limit for the assessment of android fat was the top of the iliac crest and the cephalic limit was 20% of the distance from there to the base of the skull. The total height of the gynoid region was 2 times the height of the android region and its cephalic limit started 1.5 times the height of the android region below the top of the iliac crest. The android to gynoid fat ratio was calculated. The body fat %, FMI and FFMI were reported as percentiles, according to the reference population tables [27] , which are stratified by ethnicity, age and gender (the 50th percentile reflects the median of the reference population).
Statistical analysis
The data were analysed using SPSS Statistics v. 22.0 for Windows (IBM Corp., Armonk, NY, USA). Categorical variables were described as frequencies and/or percentages, and quantitative variables were described as mean and 
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According to the BMI-based classification there was a significantly higher proportion of obese women compared with men, and a significantly higher proportion of overweight in men compared with women. None of the patients was underweight. Women had significantly higher fat mass (kg), body fat % and FMI and lower fat free mass (kg) and FFMI as absolute values. Men had a significantly higher android to gynoid fat ratio (Table 2) . In comparison with the reference population, after adjusting for age and gender, women had similar body fat % and FMI percentiles compared with men, and a significantly higher FFMI percentile (56th percentile in women compared with 32nd percentile in men, P < 0.001) (Fig. 1) .
After multivariate analysis in the whole group, female gender and age were significantly associated with a higher body fat content, whereas very high disease activity (ASDAS CRP >3.5) was related to a lower fat free mass. A longer disease duration (years since diagnosis) was significantly correlated with a higher FFMI and FFMI percentile (Table 3) .
In men multivariate analysis revealed a significant association between a high disease activity (ASDAS CRP >3.5 or BASDAI 54) and lower body fat %, fat mass or FMI percentile. In contrast, we found in women that a high disease activity (ASDAS >3.5 or BASDAI 54) was significantly related to a higher body fat %, FMI or FMI percentile (Table 4 ) (univariate analysis results are shown in supplementary Tables S1 and S2, available at Rheumatology Online).
Dyslipidaemia
In the univariate analysis, male gender, psoriasis, alcohol use, NSAIDs use, overweight, the android to gynoid fat ratio, body fat % percentile and FMI percentile were significantly associated with dyslipidaemia (supplementary Table S3 , available at Rheumatology Online).
The multivariate analysis showed that only higher values of the android to gynoid fat ratio [odds ratio (OR) = 566, 95% CI: 1.78, 180105], body fat % percentile (OR = 1.1, 95% CI: 1, 1.1) and FMI percentile (OR = 1.1, 95% CI: 1, 1.1) remained significantly associated with the presence of dyslipidaemia. There were no other relevant results when women and men were analysed separately.
Hypertension
In the univariate analysis, age, years with symptoms, NSAIDs use, BMI and body fat % percentile were related to the presence of hypertension (supplementary Table S3 , available at Rheumatology Online). In the multivariate analysis, only age remained to be associated with hypertension (OR = 1.2, 95% CI: 1.1, 1.3). In men, after multivariate analysis, BMI (OR = 1.7, 95% CI: 1.1, 2.6), body fat % percentile (OR = 1.06, 95% CI: 1.02, 1.1) and FMI percentile (OR = 1.07, 95% CI: 1.03, 1.1) were significantly related to hypertension. These associations were not significant for women.
Discussion
In our study we found that muscle wasting, measured by DXA as a low FFMI compared with the reference population, was present in male TNF-a blocker naïve AS, especially in those with active disease. In addition, women had higher volumes of body fat (fat mass, body fat % and FMI) than men, but below the median values of the reference population. The presence of low FFMI could be a sign of cachexia. Cachexia is defined as a loss of lean tissue mass, with a weight loss >5% of body weight in 12 months (or less in the presence of a chronic illness), or as a BMI lower than 20, plus three of the following: decreased muscle strength, fatigue, anorexia, low FFMI, increase of inflammation markers such as CRP or IL-6, anaemia or low serum albumin [28] . There is a proposal to combine the concepts of muscle wasting, sarcopenia, frailty and cachexia under the term muscle wasting disease [29] . The hypothesis for cachexia in AS is that the chronic inflammation driven by TNF-a induces anorexia, increases resting energy expenditure, induces muscle loss and down-regulates anabolic hormones and growth factors [3032] . Less appendicular (arms and legs) LM (6 kg less than controls) was reported in one study of 19 male patients with long-standing AS, and interpreted as preliminary evidence for cachexia [33] . In our study, the mean fat free mass in men was 5.5 kg lower than the reference population [34] . A recently published study reported a slightly lower fat free mass and FFMI in male AS patients compared with controls, but the percentiles were not reported, and therefore, it was not controlled by ethnicity or age. In addition, one-third of the patients were using TNFa blockers that could affect the BC [35] . Other studies, with similar limitations, did not find differences between patients and controls [8, 3638] . The results of our study suggest the presence of muscle wasting, especially in male patients and in those with active disease by ASDAS CRP. In order to confirm whether the patients fulfil the criteria of cachexia we should have had at least 12 months of follow-up, which we considered unethical because all these patients needed treatment with TNF-a blockers. Interestingly, our data showed that longer disease duration was significantly associated with a higher FFMI and a higher FFMI percentile, probably due to anti-inflammatory treatment and the start of physiotherapy after the diagnosis was made, showing some muscle recovery. TNF-a blockers would be expected to improve or prevent muscle wasting in rheumatoid arthritis and AS, but the available data are not conclusive [32, 39] .
The android fat distribution refers to abdominal fat that can be subclassified in subcutaneous and visceral adipose tissue (VAT). VAT is an active tissue and is capable of releasing bioactive molecules and hormones, including adipokines such as leptin, adiponectin, resistin, visfatin, TNF and IL-6. Moreover, VAT is considered to be more strongly related to various obesity-associated processes and autoimmune inflammatory conditions than other indexes such as BMI [8, 4046] . The android to gynoid fat ratio measured by DXA has a strong correlation with VAT and cardiovascular risk [47] . In our study, we found a significant association between body fat % percentile, FMI percentile and, especially, the android to gynoid fat ratio with dyslipidaemia, supporting the relation between VAT and cardiovascular risk. We did not find an association between BMI and dyslipidaemia.
In women we found that higher body fat %, FMI and FMI percentile were associated with a higher disease activity (ASDAS), but in men we found the opposite. One hypothesis that might explain this observation is that as the fat content characteristics differ by gender, with higher android fat content in men and gynoid fat content in women, adipokines also could differ, and therefore the relationship of type of adipose tissue with inflammation. However, due to the limited number of patients in our study, more data are needed to confirm this relationship.
Another limitation is the absence of specific appendicular LM information, which some authors consider a better measurement than total LM to assess the presence of muscle wasting.
The strength of our study is the use of percentiles according to the reference population, avoiding the problems of other studies regarding the effect of age, ethnicity and gender in BC [48] .
In conclusion, male AS patients and those with active disease have a lower fat free mass content compared with the reference population, suggesting the presence of muscle wasting as a result of chronic illness and inflammation.
